MedPath
TGA Approval

LAZCLUZE lazertinib 80 mg film-coated tablets blister pack (444772)

444772

LAZCLUZE lazertinib 80 mg film-coated tablets blister pack

Janssen-Cilag Pty Ltd

April 15, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ed706348112b779c5434b64d35f56726.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/f1ca70c48bb74241e4001672e93ca946.pdf

Active Ingredients

lazertinib mesilate monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LAZCLUZE lazertinib 80 mg film-coated tablets blister pack (444772) - TGA 批准文号 | MedPath